Anti-human P40 protein domain antibody and use thereof

USPTO granted Patent US12595300B2 to Akeso Biopharma, Inc. for an antibody targeting human P40 protein for autoimmune disease treatment. The patent protects specific heavy chain and light chain variable region amino acid sequences and their use in treating autoimmune conditions, with 20 claims total.

Affected parties including pharmaceutical companies, biotechnology firms, and researchers working on P40-targeting therapies should be aware that this patent grants Akeso Biopharma exclusive rights to these specific antibody sequences for autoimmune disease applications. Parties developing competing therapies targeting the same protein may need to obtain licenses or design alternative antibody sequences to avoid infringement.